The HIV/AIDS response as we knew it is over: Where do we go from here?
Journal of the International AIDS Society · 2026-02 · 29 (2)
DOI: 10.1002/jia2.70077 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the International AIDS Society, online erschienen am 20.02.2026. Verfasst von Chris Beyrer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Duke Global Health Institute, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Acquired Immunodeficiency Syndrome, HIV Infections, Preventive Health Services. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Introduction
The global HIV response, once a model of progress and innovation, faces a profound moment. Despite four decades of pivotal scientific and programmatic advances—most notably in antiretroviral therapy (ART) and pre‐exposure prophylaxis (PrEP)—the world remains off track to meet the 2025 and 2030 targets for ending AIDS as a public health threat. New acquisitions and AIDS‐related deaths remain unacceptably high, particularly among key populations and in low‐ and middle‐income countries. The abrupt U.S. funding reversals in 2025 have severely disrupted support for HIV efforts. Cuts to U.S. and international institutions have compromised HIV prevention, treatment and surveillance systems worldwide, and may already have begun reversing two decades of progress.
Discussion
To avert this crisis, the HIV and public health community, together with governments and global funders, must urgently invest in scaling long‐acting treatment and prevention tools, rebuild disaggregated data systems and strengthen implementation science rooted in community‐led approaches. Digital health technologies offer promise to enhance service delivery, surveillance, monitoring and evaluation, especially in resource‐constrained settings, but demand ethical governance and infrastructure investment. The global research ecosystem must become more evenly distributed and inclusive, with a shift towards country‐led partnerships, national data sovereignty and regional co‐operation.
Conclusions
Looking to 2030 and beyond, the strategy to end HIV should include expanded access to long‐acting ART and PrEP, sustained investments in HIV vaccine and cure research, and robust monitoring and evaluation systems. Achieving epidemic control—and ultimately ending the HIV pandemic—will require not only biomedical tools but also political will, community leadership and equitable financing. The lessons of the past underscore that sustained progress is possible, but only if we meet this moment with urgency, imagination and solidarity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Duke Global Health Institute, Durham, North Carolina, USA.
- UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
- Fred Hutch Cancer Center, Seattle, Washington, USA.
- Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
- University of California, San Francisco, California, USA.
- South African Medical Research Council, Cape Town, South Africa.
Förderung
- NIAID NIH HHS
Zitieren
APA
Beyrer, C., Ratevosian, J., Carpino, T., Rosenberg, N. E., Gelderblom, H. C., Sullivan, P. S., Deeks, S. G., & Gray, G. (2026). The HIV/AIDS response as we knew it is over: Where do we go from here?. Journal of the International AIDS Society, 29(2). https://doi.org/10.1002/jia2.70077
Vancouver
Beyrer C, Ratevosian J, Carpino T, Rosenberg NE, Gelderblom HC, Sullivan PS, et al. The HIV/AIDS response as we knew it is over: Where do we go from here?. Journal of the International AIDS Society. 2026;29(2). doi:10.1002/jia2.70077
BibTeX
@article{Beyrer2026,
author = {Beyrer, Chris and Ratevosian, Jirair and Carpino, Tom and Rosenberg, Nora E and Gelderblom, Huub C and Sullivan, Patrick S and Deeks, Steve G and Gray, Glenda},
title = {The HIV/AIDS response as we knew it is over: Where do we go from here?},
journal = {Journal of the International AIDS Society},
year = {2026},
volume = {29},
number = {2},
doi = {10.1002/jia2.70077}
}
EUVIMED